12th Mar 2025 · SEBI-Registered Analyst
Breakout Stocks & Swing Trading · 12th Mar 2025
ALKEM
ALKEM AlkemLabs launches generic Empagliflozin & its combinations in India under brand name ‘Empanorm’
Alert: Empagliflozin is used in treatment of type-2 diabetes Mellitus, Chronic Kidney Disease
#StockInNews#TechnicalViews#FundamentalViews
102 likes·58 comments